← Back to Bills
S 5353118th CongressFailed / ExpiredSenate

National Plan for Epilepsy Act

Policy Area: Health
View on Congress.gov
Origin Chamber
Senate
Last Updated
Apr 10, 2026
Latest Action Date
Nov 20, 2024

Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The National Plan for Epilepsy Act (S.5353) was a Senate bill introduced in the 118th Congress aimed at establishing a coordinated national strategy to address epilepsy. The bill intended to improve research, treatment, and public awareness related to epilepsy, a neurological disorder characterized by recurrent seizures. Although the full text and detailed summary are not available, the bill was referred to the Senate Committee on Health, Education, Labor, and Pensions for further consideration. The bill ultimately failed or expired without becoming law.

Bottom Line

S.5353 sought to create a national framework to enhance epilepsy-related health outcomes but did not advance beyond committee referral and expired without enactment.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill was introduced in the Senate during the 118th Congress and referred to the Committee on Health, Education, Labor, and Pensions.
  • Its focus was on developing a national plan to address epilepsy through improved research, treatment, and awareness.
  • The bill did not progress to a vote and is currently classified as failed or expired.
Who Benefits?

['Individuals living with epilepsy', 'Healthcare providers specializing in neurological disorders', 'Federal health agencies involved in neurological research and public health', 'Epilepsy advocacy and support organizations']

Potential Concerns

['Lack of detailed information on funding mechanisms and resource allocation for the national plan.', 'Unclear oversight and enforcement provisions due to absence of full bill text.', 'Potential challenges in coordinating multiple federal agencies and stakeholders without explicit authority or structure outlined.']

Political Context

The bill was introduced in the Senate and referred to the relevant health committee but did not advance further. Its failure to progress may reflect legislative priorities or competing health policy agendas during the 118th Congress. The absence of a detailed summary or full text limits insight into specific legislative negotiations or support.

Hidden Impact Review

Hidden impact flags detected: 2

GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

2 Detected
Detected Flags
Indirect Effects

['Improved coordination of epilepsy research and treatment could enhance overall neurological health outcomes.', 'Increased public awareness efforts might reduce stigma associated with epilepsy.', 'Potential for federal agencies to develop new partnerships or programs focused on epilepsy.']

GovScope Watchdog Notes

The absence of a full bill text and official summary limits comprehensive analysis. Transparency about funding, authority, and oversight provisions is essential for evaluating the feasibility and impact of national health plans. Monitoring future legislative efforts on epilepsy could benefit from improved disclosure of these elements.

Passage Likelihood: LowConfidence: 70%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready